COST
Price
$994.50
Change
+$26.75 (+2.76%)
Updated
Apr 17 closing price
Capitalization
441.24B
41 days until earnings call
JNJ
Price
$157.47
Change
+$3.56 (+2.31%)
Updated
Apr 17 closing price
Capitalization
380.22B
94 days until earnings call
PG
Price
$170.63
Change
+$4.24 (+2.55%)
Updated
Apr 17 closing price
Capitalization
381.78B
5 days until earnings call
Ad is loading...

COST or JNJ or PG

Header iconCOST vs JNJ vs PG Comparison
Open Charts COST vs JNJ vs PGBanner chart's image
Costco Wholesale
Price$994.50
Change+$26.75 (+2.76%)
Volume$2.71M
Capitalization441.24B
Johnson & Johnson
Price$157.47
Change+$3.56 (+2.31%)
Volume$10.98M
Capitalization380.22B
Procter & Gamble
Price$170.63
Change+$4.24 (+2.55%)
Volume$7.23M
Capitalization381.78B
COST vs JNJ vs PG Comparison Chart
Loading...
COST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (COST: $994.50JNJ: $157.47PG: $170.63)
Brand notoriety: COST, JNJ and PG are all notable
COST represents the Discount Stores industry, JNJ is part of the Pharmaceuticals: Major industry, and PG is in the Household/Personal Care industry.
Current volume relative to the 65-day Moving Average: COST: 105%, JNJ: 106%, PG: 84%
Market capitalization -- COST: $441.24B, JNJ: $380.22B, PG: $381.78B
COST [@Discount Stores] is valued at $441.24B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $380.22B. PG [@Household/Personal Care] has a market capitalization of $381.78B. The market cap for tickers in the [@Discount Stores] industry ranges from $747.33B to $0. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The market cap for tickers in the [@Household/Personal Care] industry ranges from $381.78B to $0. The average market capitalization across the [@Discount Stores] industry is $91.18B. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B. The average market capitalization across the [@Pharmaceuticals: Major] industry is $25.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COST’s FA Score shows that 4 FA rating(s) are green whileJNJ’s FA Score has 2 green FA rating(s), and PG’s FA Score reflects 2 green FA rating(s).

  • COST’s FA Score: 4 green, 1 red.
  • JNJ’s FA Score: 2 green, 3 red.
  • PG’s FA Score: 2 green, 3 red.
According to our system of comparison, PG is a better buy in the long-term than COST, which in turn is a better option than JNJ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COST’s TA Score shows that 5 TA indicator(s) are bullish while JNJ’s TA Score has 4 bullish TA indicator(s), and PG’s TA Score reflects 7 bullish TA indicator(s).

  • COST’s TA Score: 5 bullish, 4 bearish.
  • JNJ’s TA Score: 4 bullish, 6 bearish.
  • PG’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, COST and PG are a better buy in the short-term than JNJ.

Price Growth

COST (@Discount Stores) experienced а +3.13% price change this week, while JNJ (@Pharmaceuticals: Major) price change was +5.90% , and PG (@Household/Personal Care) price fluctuated +4.32% for the same time period.

The average weekly price growth across all stocks in the @Discount Stores industry was +4.32%. For the same industry, the average monthly price growth was +9.52%, and the average quarterly price growth was -0.65%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.49%. For the same industry, the average monthly price growth was -6.12%, and the average quarterly price growth was -11.03%.

The average weekly price growth across all stocks in the @Household/Personal Care industry was +1.84%. For the same industry, the average monthly price growth was -1.51%, and the average quarterly price growth was -9.21%.

Reported Earning Dates

COST is expected to report earnings on May 30, 2025.

JNJ is expected to report earnings on Jul 22, 2025.

PG is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Discount Stores (+4.32% weekly)

Companies in the discount stores industry specialize in offering substantial discounts on a vast array of retail products. Some companies in this industry also operate general merchandise warehouse clubs. Products sold at discount stores are typically similar to those of any department store, but the pricing of the goods is generally much lower (and hence the name “discount”). Think Dollar General Corporation, Dollar Tree, Inc. and Five Below, Inc. Many discount stores target low-income households and/or price-sensitive consumers as their potential market. Discount stores’ profitability could hinge on factors like competitive pricing, sufficient locations, healthy revenue per square foot, and effective advertisement. These store operators could have an edge over other retailers during financial crises or recessions, when many consumers could be looking for less expensive alternatives.

@Pharmaceuticals: Major (+3.49% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Household/Personal Care (+1.84% weekly)

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COST($441B) has a higher market cap than PG($382B) and JNJ($380B). COST has higher P/E ratio than JNJ and PG: COST (58.06) vs JNJ (30.34) and PG (26.90). JNJ YTD gains are higher at: 9.757 vs. COST (8.658) and PG (2.398). JNJ and PG has higher annual earnings (EBITDA): 23.3B and 22.6B vs. COST (12.6B). JNJ has more cash in the bank: 22.9B vs. COST (13.2B) and PG (7.89B). COST has less debt than JNJ and PG: COST (8.04B) vs JNJ (29.3B) and PG (33.7B). COST has higher revenues than JNJ and PG: COST (264B) vs JNJ (85.2B) and PG (83.9B).
COSTJNJPG
Capitalization441B380B382B
EBITDA12.6B23.3B22.6B
Gain YTD8.6589.7572.398
P/E Ratio58.0630.3426.90
Revenue264B85.2B83.9B
Total Cash13.2B22.9B7.89B
Total Debt8.04B29.3B33.7B
FUNDAMENTALS RATINGS
COST vs JNJ vs PG: Fundamental Ratings
COST
JNJ
PG
OUTLOOK RATING
1..100
837472
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
18
Undervalued
46
Fair valued
PROFIT vs RISK RATING
1..100
42013
SMR RATING
1..100
304532
PRICE GROWTH RATING
1..100
255250
P/E GROWTH RATING
1..100
225742
SEASONALITY SCORE
1..100
n/a50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JNJ's Valuation (18) in the Pharmaceuticals Major industry is in the same range as PG (46) in the Household Or Personal Care industry, and is significantly better than the same rating for COST (97) in the Specialty Stores industry. This means that JNJ's stock grew similarly to PG’s and significantly faster than COST’s over the last 12 months.

COST's Profit vs Risk Rating (4) in the Specialty Stores industry is in the same range as PG (13) in the Household Or Personal Care industry, and is in the same range as JNJ (20) in the Pharmaceuticals Major industry. This means that COST's stock grew similarly to PG’s and similarly to JNJ’s over the last 12 months.

COST's SMR Rating (30) in the Specialty Stores industry is in the same range as PG (32) in the Household Or Personal Care industry, and is in the same range as JNJ (45) in the Pharmaceuticals Major industry. This means that COST's stock grew similarly to PG’s and similarly to JNJ’s over the last 12 months.

COST's Price Growth Rating (25) in the Specialty Stores industry is in the same range as PG (50) in the Household Or Personal Care industry, and is in the same range as JNJ (52) in the Pharmaceuticals Major industry. This means that COST's stock grew similarly to PG’s and similarly to JNJ’s over the last 12 months.

COST's P/E Growth Rating (22) in the Specialty Stores industry is in the same range as PG (42) in the Household Or Personal Care industry, and is somewhat better than the same rating for JNJ (57) in the Pharmaceuticals Major industry. This means that COST's stock grew similarly to PG’s and somewhat faster than JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COSTJNJPG
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
30%
Bearish Trend 2 days ago
41%
Bullish Trend 2 days ago
48%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
42%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
46%
Bullish Trend 2 days ago
33%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
42%
Bullish Trend 2 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
42%
Bullish Trend 2 days ago
41%
Advances
ODDS (%)
Bullish Trend 10 days ago
66%
Bullish Trend 2 days ago
40%
Bullish Trend 5 days ago
45%
Declines
ODDS (%)
Bearish Trend 3 days ago
38%
Bearish Trend 11 days ago
42%
Bearish Trend 3 days ago
38%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
60%
Aroon
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
34%
Bearish Trend 2 days ago
31%
View a ticker or compare two or three
Ad is loading...
COST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPS12.180.38
+3.22%
Cooper-Standard Automotive
GOOS8.010.23
+2.96%
Canada Goose Holdings
ALLK0.33N/A
+0.93%
Allakos
MPLX50.570.35
+0.70%
Mplx LP
UBSI33.510.07
+0.21%
United Bankshares

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+2.31%
PFE - JNJ
59%
Loosely correlated
+0.45%
NVS - JNJ
48%
Loosely correlated
+1.17%
GSK - JNJ
46%
Loosely correlated
+1.58%
SNY - JNJ
42%
Loosely correlated
+0.67%
GILD - JNJ
41%
Loosely correlated
-0.32%
More

PG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PG has been closely correlated with CL. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if PG jumps, then CL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PG
1D Price
Change %
PG100%
+2.55%
CL - PG
79%
Closely correlated
+2.72%
KMB - PG
72%
Closely correlated
+2.23%
CHD - PG
67%
Closely correlated
+2.34%
CLX - PG
57%
Loosely correlated
+2.18%
UL - PG
49%
Loosely correlated
+2.03%
More